Serum IFN‐γ and IL‐10 levels are associated with disease progression in non‐obese diabetic mice
- 1 January 2002
- journal article
- research article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 18 (1) , 64-70
- https://doi.org/10.1002/dmrr.256
Abstract
Background: The goal of the present study was to determine whether cytokines in the peripheral blood of naive NOD mice correlate with the disease process and thereby would provide a marker for monitoring disease activity.Methods: Female NOD mice (5, 10 and 14–16 weeks of age) were investigated in a cross‐sectional study. In the group of 14–16‐week‐old mice, non‐diabetic and diabetic mice were analysed as different subgroups. The Th1 cytokine (IFN‐γ) and the Th2 cytokine (IL‐10) were quantified in serum by sandwich enzyme‐linked immunosorbent assay (ELISA). Pancreatic mRNA for IFN‐γ and IL‐10 was determined by reverse transcriptase‐polymerase chain reaction (RT‐PCR) from the same animals.Results: Serum levels of IFN‐γ were initially low but increased with age in NOD mice, reaching the highest levels at diabetes onset (pp<0.005).Conclusion: These results demonstrate, for the first time, that an increased Th2 pattern in the non‐diabetic stage preceding a Th1 shift is associated with the development of diabetes in naive NOD mice. Serum cytokines correlate with disease progression and pancreatic cytokine expression during prediabetes. Soluble cytokines measured in the periphery are therefore promising surrogate markers of diabetes development. Copyright © 2002 John Wiley & Sons, Ltd.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft
- Bundesminister für Gesundheit
- Minister für Wissenschaft und Forschung des Landes Nordrhein-Westfalen
This publication has 35 references indexed in Scilit:
- Prevention of autoimmune diabetes by intramuscular gene therapy with a nonviral vector encoding an interferon-gamma receptor/IgG1 fusion proteinGene Therapy, 1999
- Th1-like Cytokine Production Profile and Individual Specific Alterations in TCRBV-gene Usage of T Cells from Newly Diagnosed Type 1 Diabetes Patients after Stimulation with β-cell AntigensJournal of Autoimmunity, 1997
- Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients.Journal of Clinical Investigation, 1997
- Prevention of adoptively transferred diabetes in nonobese diabetic mice with IL-10-transduced islet-specific Th1 lymphocytes. A gene therapy model for autoimmune diabetes.Journal of Clinical Investigation, 1996
- IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity.The Journal of Experimental Medicine, 1996
- In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice.Journal of Clinical Investigation, 1995
- T Helper Cell Subsets in Insulin-Dependent DiabetesScience, 1995
- Regulation of IFN-γ mRNA production in murine natural killer cellsInternational Immunology, 1995
- Recombinant Human IL-10 Prevents the Onset of Diabetes in the Nonobese Diabetic MouseClinical Immunology and Immunopathology, 1994
- Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice.The Journal of Experimental Medicine, 1994